| Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors TL Chenevert, LD Stegman, JMG Taylor, PL Robertson, HS Greenberg, ... JNCI: Journal of the National Cancer Institute 92 (24), 2029-2036, 2000 | 814 | 2000 |
| Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response BA Moffat, TL Chenevert, TS Lawrence, CR Meyer, TD Johnson, Q Dong, ... Proceedings of the national academy of sciences 102 (15), 5524-5529, 2005 | 796 | 2005 |
| Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression CJ Galbán, MK Han, JL Boes, KA Chughtai, CR Meyer, TD Johnson, ... Nature medicine 18 (11), 1711-1715, 2012 | 778 | 2012 |
| CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature Z Miao, KE Luker, BC Summers, R Berahovich, MS Bhojani, A Rehemtulla, ... Proceedings of the National Academy of Sciences 104 (40), 15735-15740, 2007 | 739 | 2007 |
| Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy AM Chinnaiyan, U Prasad, S Shankar, DA Hamstra, M Shanaiah, ... Proceedings of the National Academy of Sciences 97 (4), 1754-1759, 2000 | 673 | 2000 |
| Vascular targeted nanoparticles for imaging and treatment of brain tumors GR Reddy, MS Bhojani, P McConville, J Moody, BA Moffat, DE Hall, ... Clinical Cancer Research 12 (22), 6677-6686, 2006 | 613 | 2006 |
| Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging A Rehemtulla, LD Stegman, SJ Cardozo, S Gupta, DE Hall, CH Contag, ... Neoplasia 2 (6), 491-495, 2000 | 596 | 2000 |
| Brain cancer diagnosis and therapy with nanoplatforms YEL Koo, GR Reddy, M Bhojani, R Schneider, MA Philbert, A Rehemtulla, ... Advanced drug delivery reviews 58 (14), 1556-1577, 2006 | 409 | 2006 |
| Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology DA Hamstra, A Rehemtulla, BD Ross Journal of clinical oncology 25 (26), 4104-4109, 2007 | 389 | 2007 |
| Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma DA Hamstra, TL Chenevert, BA Moffat, TD Johnson, CR Meyer, ... Proceedings of the National Academy of Sciences 102 (46), 16759-16764, 2005 | 371 | 2005 |
| Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1) A Rehemtulla, CA Hamilton, AM Chinnaiyan, VM Dixit Journal of Biological Chemistry 272 (41), 25783-25786, 1997 | 362 | 1997 |
| Noninvasive real-time imaging of apoptosis B Laxman, DE Hall, MS Bhojani, DA Hamstra, TL Chenevert, BD Ross, ... Proceedings of the National Academy of Sciences 99 (26), 16551-16555, 2002 | 357 | 2002 |
| Phospholipid-independent and-dependent interactions required for tissue factor receptor and cofactor function W Ruf, A Rehemtulla, JH Morrissey, TS Edgington Journal of Biological Chemistry 266 (4), 2158-2166, 1991 | 345 | 1991 |
| Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival DA Hamstra, CJ Galbán, CR Meyer, TD Johnson, PC Sundgren, C Tsien, ... Journal of clinical oncology 26 (20), 3387, 2008 | 327 | 2008 |
| Evaluation of cancer therapy using diffusion magnetic resonance imaging BD Ross, BA Moffat, TS Lawrence, SK Mukherji, SS Gebarski, DJ Quint, ... Molecular cancer therapeutics 2 (6), 581-587, 2003 | 318 | 2003 |
| Tissue factor: an enzyme cofactor and a true receptor JH Morrissey Thrombosis and haemostasis 86 (07), 66-74, 2001 | 309 | 2001 |
| Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts E Kievit, E Bershad, E Ng, P Sethna, I Dev, TS Lawrence, A Rehemtulla Cancer research 59 (7), 1417-1421, 1999 | 267 | 1999 |
| The basic motif-leucine zipper transcription factor Nrl can positively regulate rhodopsin gene expression. A Rehemtulla, R Warwar, R Kumar, X Ji, DJ Zack, A Swaroop Proceedings of the National Academy of Sciences 93 (1), 191-195, 1996 | 260 | 1996 |
| Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma C Tsien, CJ Galbán, TL Chenevert, TD Johnson, DA Hamstra, ... Journal of Clinical Oncology 28 (13), 2293, 2010 | 250 | 2010 |
| The parametric response map is an imaging biomarker for early cancer treatment outcome CJ Galbán, TL Chenevert, CR Meyer, C Tsien, TS Lawrence, DA Hamstra, ... Nature medicine 15 (5), 572-576, 2009 | 243 | 2009 |
